This is a Validated Antibody Database (VAD) review about dog BCL2L11, based on 52 published articles (read how Labome selects the articles), using BCL2L11 antibody in all methods. It is aimed to help Labome visitors find the most suited BCL2L11 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BCL2L11 synonym: bcl-2-like protein 11; bcl-2-like protein 11-like

Cell Signaling Technology
rabbit monoclonal (C34C5)
  • western blot; mouse; loading ...; fig s3i
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples (fig s3i). Science (2019) ncbi
rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3e
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6b
Cell Signaling Technology BCL2L11 antibody (CST, 2933) was used in immunohistochemistry - paraffin section on human samples (fig 3e) and in immunohistochemistry - paraffin section on mouse samples (fig 6b). Nat Commun (2019) ncbi
rabbit monoclonal (C34C5)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
  • western blot; mouse; 1:1000; loading ...; fig 1e
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in immunohistochemistry on mouse samples at 1:400 (fig 1a) and in western blot on mouse samples at 1:1000 (fig 1e). Neuroscience (2019) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig 3b
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2018) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples (fig 4c). Nat Med (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples (fig 4c). Anticancer Res (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in western blot on mouse samples at 1:1000 (fig 2c). Nat Commun (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology BCL2L11 antibody (cell signalling, 2933) was used in western blot on human samples at 1:1000 (fig 8b). Int J Oncol (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig s4k
Cell Signaling Technology BCL2L11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig s4k). EMBO J (2017) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse; fig 6j
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 6j). Proc Natl Acad Sci U S A (2017) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig 3a
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology BCL2L11 antibody (cell signalling, 4581) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 2b
In order to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 2b). Biochem Biophys Res Commun (2017) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig s8d
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig s8d). Nature (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933S) was used in western blot on human samples (fig 4b). Sci Rep (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 4
Cell Signaling Technology BCL2L11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse; loading ...; fig s2b
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse; 1:200
  • western blot; mouse; 1:1000; fig 3
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in flow cytometry on mouse samples at 1:200 and in western blot on mouse samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Tech, 2933S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; human; loading ...; fig 6
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Cell Signaling Technology BCL2L11 antibody (cell signalling, C34C5) was used in flow cytometry on human samples (fig 6). J Clin Invest (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 3
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 3). Cancer Cell Int (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1c
In order to elucidate the mechanism of cisplatin-induced non-small-cell lung cancer cell apoptosis, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 1c). Biochem Biophys Res Commun (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; fig 1e
In order to evaluate the antitumor activity of the pan-HDAC inhibitor, panobinostat, in mice, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples at 1:1000 (fig 1e). Int J Cancer (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology BCL2L11 antibody (Cell Signaling Tech, 2933) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • flow cytometry; mouse
In order to examine the contribution of Foxo1 to activated T cells, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 6
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 6
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 6). Front Genet (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 4
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933S) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 1
In order to study the effects of HDAC inhibitors and BCL-2 inhibitors on small cell lung cancer lines, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in western blot on human samples (fig 1). Cancer Biol Ther (2016) ncbi
rabbit monoclonal (D7E11)
  • immunohistochemistry; mouse; 1:400; loading ...; fig s6a
In order to evaluate the use of phenformin with MLN0128 as a treatment strategy for non-small cell lung carcinoma, Cell Signaling Technology BCL2L11 antibody (Cell signaling, 4585) was used in immunohistochemistry on mouse samples at 1:400 (fig s6a). Cancer Res (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 7b
  • western blot; mouse; loading ...; fig s8
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 7b) and in western blot on mouse samples (fig s8). Oncotarget (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 2
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology BCL2L11 antibody (CST, 2933) was used in immunohistochemistry - paraffin section on human samples . Nature (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology BCL2L11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 6b). Oncotarget (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 3
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Tech, C34C5) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:5000; fig 4
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:5000 (fig 4). Infect Immun (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 6
In order to investigate the role of RIPK1 in response to endoplasmic reticulum stress, Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 4581) was used in western blot on human samples (fig 6). Autophagy (2015) ncbi
rabbit monoclonal (C34C5)
  • immunohistochemistry - paraffin section; dog
  • western blot; dog
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in immunohistochemistry - paraffin section on dog samples and in western blot on dog samples . Int J Oncol (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 8
In order to analyze thyroid hormone receptor beta for oncogenic mutations, Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 2933) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 2
Cell Signaling Technology BCL2L11 antibody (Cell signaling, 2933) was used in western blot on human samples (fig 2). Pigment Cell Melanoma Res (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples . J Biol Chem (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; fig 5
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples (fig 5). Biomed Res Int (2015) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000; fig 3
In order to assess the efficacy of alisertib against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples at 1:1000 (fig 3). Cancer Res (2014) ncbi
rabbit monoclonal (C34C5)
  • western blot; mouse; 1:1000; fig 6
In order to investigate whether drugs that increase Hsp70/Hsp110 levels protect cells from traumatic brain injury, Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on mouse samples at 1:1000 (fig 6). J Neurochem (2014) ncbi
rabbit monoclonal (C34C5)
  • western blot; human
In order to evaluate the effect of Noxa on the localization and stability of MCL-1 in small cell lung cancer, Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, C34C5) was used in western blot on human samples . Cell Death Dis (2014) ncbi
rabbit monoclonal (C34C5)
  • western blot; human
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, 2933) was used in western blot on human samples . Cell Death Dis (2014) ncbi
rabbit monoclonal (C34C5)
  • western blot; mouse
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technology, 2933) was used in western blot on mouse samples . J Neurosci (2013) ncbi
rabbit monoclonal (C34C5)
  • western blot; human; 1:1000
Cell Signaling Technology BCL2L11 antibody (Cell Signaling Technologies, C34C5) was used in western blot on human samples at 1:1000. Cell Death Differ (2013) ncbi
rabbit monoclonal (C34C5)
  • western blot; mouse
Cell Signaling Technology BCL2L11 antibody (Cell Signaling, C34C5) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
Articles Reviewed
  1. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  2. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  3. Hu K, Huang Q, Liu C, Li Y, Liu Y, Wang H, et al. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. Neuroscience. 2019;399:117-124 pubmed publisher
  4. Mittelstadt P, Taves M, Ashwell J. Cutting Edge: De Novo Glucocorticoid Synthesis by Thymic Epithelial Cells Regulates Antigen-Specific Thymocyte Selection. J Immunol. 2018;200:1988-1994 pubmed publisher
  5. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  6. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed publisher
  7. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  8. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed publisher
  9. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  10. Wang X, Cao W, Zhang J, Yan M, Xu Q, Wu X, et al. A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination. EMBO J. 2017;36:1243-1260 pubmed publisher
  11. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  12. Hsu L, Cheng D, Chen Y, Liang H, Weiss A. Destabilizing the autoinhibitory conformation of Zap70 induces up-regulation of inhibitory receptors and T cell unresponsiveness. J Exp Med. 2017;214:833-849 pubmed publisher
  13. Li Y, Buijs Gladdines J, Canté Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  14. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed publisher
  15. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  16. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed publisher
  17. Bahr J, Robey R, Luchenko V, Basseville A, Chakraborty A, Kozlowski H, et al. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016;7:69804-69815 pubmed publisher
  18. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  19. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  20. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed publisher
  21. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed publisher
  22. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  23. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  24. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed publisher
  25. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed publisher
  26. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed publisher
  27. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  28. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  29. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  30. Jin H, Gonzalez Martin A, Miletic A, Lai M, Knight S, Sabouri Ghomi M, et al. Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015;6:340 pubmed publisher
  31. Dupont T, Yang S, Patel J, Hatzi K, Malik A, Tam W, et al. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma. Oncotarget. 2016;7:3520-32 pubmed publisher
  32. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed publisher
  33. Momcilovic M, McMickle R, Abt E, Seki A, Simko S, Magyar C, et al. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Res. 2015;75:4910-22 pubmed publisher
  34. Moncunill Massaguer C, Saura Esteller J, Pérez Perarnau A, Palmeri C, Núñez Vázquez S, Cosialls A, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750-65 pubmed publisher
  35. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed publisher
  36. Zhang L, Zhang S, Yao J, Lowery F, Zhang Q, Huang W, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100-104 pubmed publisher
  37. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed publisher
  38. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  39. Dille S, Kleinschnitz E, Kontchou C, Nölke T, Häcker G. In contrast to Chlamydia trachomatis, Waddlia chondrophila grows in human cells without inhibiting apoptosis, fragmenting the Golgi apparatus, or diverting post-Golgi sphingomyelin transport. Infect Immun. 2015;83:3268-80 pubmed publisher
  40. Luan Q, Jin L, Jiang C, Tay K, Lai F, Liu X, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 2015;11:975-94 pubmed publisher
  41. Andersen N, Boguslawski E, Kuk C, Chambers C, Duesbery N. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. Int J Oncol. 2015;47:71-80 pubmed publisher
  42. Park J, Zhao L, Willingham M, Cheng S. Oncogenic mutations of thyroid hormone receptor β. Oncotarget. 2015;6:8115-31 pubmed
  43. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed publisher
  44. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed publisher
  45. Huang P, Hung S, Pao C, Wang T. N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells. Biomed Res Int. 2015;2015:798489 pubmed publisher
  46. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed publisher
  47. Eroglu B, Kimbler D, Pang J, Choi J, Moskophidis D, Yanasak N, et al. Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury. J Neurochem. 2014;130:626-41 pubmed publisher
  48. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed publisher
  49. Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M, et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043 pubmed publisher
  50. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed publisher
  51. Geissler A, Haun F, Frank D, Wieland K, Simon M, Idzko M, et al. Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 2013;20:1317-29 pubmed publisher
  52. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher